25 XP   0   0   10

Medipal Holdings Corp ADR
Buy, Hold or Sell?

Let's analyse Medipal together

PenkeI guess you are interested in Medipal Holdings Corp ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medipal Holdings Corp ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medipal Holdings Corp ADR

I send you an email if I find something interesting about Medipal Holdings Corp ADR.

Quick analysis of Medipal (30 sec.)










What can you expect buying and holding a share of Medipal? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$21.93
Expected worth in 1 year
$23.16
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
$1.22
Return On Investment
7.9%

For what price can you sell your share?

Current Price per Share
$15.45
Expected price per share
$15.45 - $15.45
How sure are you?
50%

1. Valuation of Medipal (5 min.)




Live pricePrice per Share (EOD)

$15.45

Intrinsic Value Per Share

$75.65 - $90.53

Total Value Per Share

$97.58 - $112.46

2. Growth of Medipal (5 min.)




Is Medipal growing?

Current yearPrevious yearGrowGrow %
How rich?$4.6b$4.3b$267.3m5.8%

How much money is Medipal making?

Current yearPrevious yearGrowGrow %
Making money$60.5m$49.4m$11m18.3%
Net Profit Margin1.1%0.9%--

How much money comes from the company's main activities?

3. Financial Health of Medipal (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#4 / 40

Most Profit
#11 / 40

What can you expect buying and holding a share of Medipal? (5 min.)

Welcome investor! Medipal's management wants to use your money to grow the business. In return you get a share of Medipal.

What can you expect buying and holding a share of Medipal?

First you should know what it really means to hold a share of Medipal. And how you can make/lose money.

Speculation

The Price per Share of Medipal is $15.45. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medipal.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medipal, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $21.93. Based on the TTM, the Book Value Change Per Share is $0.31 per quarter. Based on the YOY, the Book Value Change Per Share is $0.45 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medipal.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.342.2%0.291.8%0.231.5%0.241.6%0.221.4%
Usd Book Value Change Per Share0.070.4%0.312.0%0.452.9%0.291.9%0.261.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.070.4%0.312.0%0.452.9%0.291.9%0.261.7%
Usd Price Per Share16.40-15.62-14.44-18.25-12.69-
Price to Earnings Ratio11.97-14.73-74.60-31.88-22.28-
Price-to-Total Gains Ratio238.37-94.26--371.12--56.12--20.36-
Price to Book Ratio0.75-0.72-0.74-0.98-0.73-
Price-to-Total Gains Ratio238.37-94.26--371.12--56.12--20.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.45
Number of shares64
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.310.29
Usd Total Gains Per Share0.310.29
Gains per Quarter (64 shares)19.6018.56
Gains per Year (64 shares)78.4074.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10786807464
201571460149138
302352240223212
403143020297286
503923800371360
604704580446434
705495360520508
806276140594582
907066920668656
1007847700743730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%56.05.00.091.8%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%33.07.00.082.5%49.011.01.080.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%9.00.052.014.8%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%33.07.00.082.5%50.011.00.082.0%

Fundamentals of Medipal

About Medipal Holdings Corp ADR

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Further, the company trades in medical clerks; outsourcing of medical administrative, and medical consulting; and distributes specialty pharmaceuticals. Additionally, it engages in contract logistics services, as well as offers information provision services. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.

Fundamental data was last updated by Penke on 2024-04-01 11:06:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Medipal Holdings Corp ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medipal earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.2% means that $0.01 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medipal Holdings Corp ADR:

  • The MRQ is 1.2%. The company is making a profit. +1
  • The TTM is 1.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.2%TTM1.1%+0.1%
TTM1.1%YOY0.9%+0.2%
TTM1.1%5Y1.0%+0.1%
5Y1.0%10Y1.0%+0.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%2.1%-0.9%
TTM1.1%2.1%-1.0%
YOY0.9%2.5%-1.6%
5Y1.0%2.2%-1.2%
10Y1.0%2.3%-1.3%
1.1.2. Return on Assets

Shows how efficient Medipal is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • 0.6% Return on Assets means that Medipal generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medipal Holdings Corp ADR:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.5%+0.1%
TTM0.5%YOY0.4%+0.1%
TTM0.5%5Y0.5%+0.0%
5Y0.5%10Y0.5%0.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%1.6%-1.0%
TTM0.5%1.7%-1.2%
YOY0.4%1.2%-0.8%
5Y0.5%1.1%-0.6%
10Y0.5%1.6%-1.1%
1.1.3. Return on Equity

Shows how efficient Medipal is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • 1.9% Return on Equity means Medipal generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medipal Holdings Corp ADR:

  • The MRQ is 1.9%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.9%TTM1.6%+0.3%
TTM1.6%YOY1.4%+0.2%
TTM1.6%5Y1.6%+0.1%
5Y1.6%10Y1.7%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%4.3%-2.4%
TTM1.6%3.7%-2.1%
YOY1.4%2.8%-1.4%
5Y1.6%3.5%-1.9%
10Y1.7%3.9%-2.2%

1.2. Operating Efficiency of Medipal Holdings Corp ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medipal is operating .

  • Measures how much profit Medipal makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • An Operating Margin of 2.0% means the company generated $0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medipal Holdings Corp ADR:

  • The MRQ is 2.0%. The company is operating less efficient.
  • The TTM is 1.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM1.5%+0.5%
TTM1.5%YOY1.4%+0.1%
TTM1.5%5Y1.6%-0.1%
5Y1.6%10Y1.7%-0.1%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%2.9%-0.9%
TTM1.5%2.9%-1.4%
YOY1.4%3.9%-2.5%
5Y1.6%3.5%-1.9%
10Y1.7%3.4%-1.7%
1.2.2. Operating Ratio

Measures how efficient Medipal is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are $0.98 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medipal Holdings Corp ADR:

  • The MRQ is 0.980. The company is less efficient in keeping operating costs low.
  • The TTM is 0.985. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.980TTM0.985-0.005
TTM0.985YOY0.986-0.001
TTM0.9855Y0.986-0.001
5Y0.98610Y0.9860.000
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9801.642-0.662
TTM0.9851.594-0.609
YOY0.9861.431-0.445
5Y0.9861.365-0.379
10Y0.9861.229-0.243

1.3. Liquidity of Medipal Holdings Corp ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medipal is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.20 means the company has $1.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medipal Holdings Corp ADR:

  • The MRQ is 1.198. The company is just able to pay all its short-term debts.
  • The TTM is 1.207. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.198TTM1.207-0.009
TTM1.207YOY1.2070.000
TTM1.2075Y1.209-0.002
5Y1.20910Y1.191+0.018
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1981.389-0.191
TTM1.2071.400-0.193
YOY1.2071.424-0.217
5Y1.2091.411-0.202
10Y1.1911.329-0.138
1.3.2. Quick Ratio

Measures if Medipal is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • A Quick Ratio of 0.93 means the company can pay off $0.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medipal Holdings Corp ADR:

  • The MRQ is 0.928. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.957. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.928TTM0.957-0.029
TTM0.957YOY0.987-0.030
TTM0.9575Y0.984-0.026
5Y0.98410Y0.968+0.015
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9280.730+0.198
TTM0.9570.745+0.212
YOY0.9870.798+0.189
5Y0.9840.784+0.200
10Y0.9680.850+0.118

1.4. Solvency of Medipal Holdings Corp ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medipal assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medipal to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.62 means that Medipal assets are financed with 62.0% credit (debt) and the remaining percentage (100% - 62.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medipal Holdings Corp ADR:

  • The MRQ is 0.620. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.606. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.606+0.014
TTM0.606YOY0.618-0.012
TTM0.6065Y0.624-0.018
5Y0.62410Y0.648-0.024
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6200.609+0.011
TTM0.6060.6060.000
YOY0.6180.600+0.018
5Y0.6240.580+0.044
10Y0.6480.586+0.062
1.4.2. Debt to Equity Ratio

Measures if Medipal is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medipal to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 200.2% means that company has $2.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medipal Holdings Corp ADR:

  • The MRQ is 2.002. The company is just not able to pay all its debts with equity.
  • The TTM is 1.885. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.002TTM1.885+0.117
TTM1.885YOY1.981-0.096
TTM1.8855Y2.023-0.138
5Y2.02310Y2.223-0.200
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0021.554+0.448
TTM1.8851.554+0.331
YOY1.9811.688+0.293
5Y2.0231.675+0.348
10Y2.2231.759+0.464

2. Market Valuation of Medipal Holdings Corp ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medipal generates.

  • Above 15 is considered overpriced but always compare Medipal to the Medical Distribution industry mean.
  • A PE ratio of 11.97 means the investor is paying $11.97 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medipal Holdings Corp ADR:

  • The EOD is 11.274. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.967. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.733. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.274MRQ11.967-0.693
MRQ11.967TTM14.733-2.766
TTM14.733YOY74.597-59.864
TTM14.7335Y31.885-17.152
5Y31.88510Y22.280+9.605
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD11.27412.427-1.153
MRQ11.96714.424-2.457
TTM14.73315.740-1.007
YOY74.59718.752+55.845
5Y31.88515.472+16.413
10Y22.28019.379+2.901
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medipal Holdings Corp ADR:

  • The EOD is 4.230. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.490. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.349. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD4.230MRQ4.490-0.260
MRQ4.490TTM12.349-7.859
TTM12.349YOY7.497+4.852
TTM12.3495Y3.969+8.380
5Y3.96910Y1.985+1.985
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD4.2307.168-2.938
MRQ4.4906.758-2.268
TTM12.34912.327+0.022
YOY7.4973.478+4.019
5Y3.9693.969+0.000
10Y1.9853.188-1.203
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medipal is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.75 means the investor is paying $0.75 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Medipal Holdings Corp ADR:

  • The EOD is 0.704. Based on the equity, the company is cheap. +2
  • The MRQ is 0.748. Based on the equity, the company is cheap. +2
  • The TTM is 0.720. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.704MRQ0.748-0.043
MRQ0.748TTM0.720+0.028
TTM0.720YOY0.739-0.019
TTM0.7205Y0.983-0.262
5Y0.98310Y0.727+0.255
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.7040.988-0.284
MRQ0.7481.157-0.409
TTM0.7201.157-0.437
YOY0.7391.208-0.469
5Y0.9831.257-0.274
10Y0.7271.922-1.195
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medipal Holdings Corp ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0690.306-78%0.446-85%0.290-76%0.258-73%
Book Value Per Share--21.93121.668+1%19.636+12%18.969+16%16.597+32%
Current Ratio--1.1981.207-1%1.207-1%1.209-1%1.191+1%
Debt To Asset Ratio--0.6200.606+2%0.618+0%0.624-1%0.648-4%
Debt To Equity Ratio--2.0021.885+6%1.981+1%2.023-1%2.223-10%
Dividend Per Share----0%-0%-0%-0%
Eps--0.3430.286+20%0.226+51%0.243+41%0.223+53%
Free Cash Flow Per Share--0.9130.420+117%0.219+316%0.353+159%0.353+159%
Free Cash Flow To Equity Per Share--0.9130.420+117%0.219+316%0.353+159%0.353+159%
Gross Profit Margin--0.5310.444+20%-1.253+336%0.069+667%0.262+103%
Intrinsic Value_10Y_max--90.531--------
Intrinsic Value_10Y_min--75.650--------
Intrinsic Value_1Y_max--2.525--------
Intrinsic Value_1Y_min--2.476--------
Intrinsic Value_3Y_max--12.576--------
Intrinsic Value_3Y_min--11.905--------
Intrinsic Value_5Y_max--28.642--------
Intrinsic Value_5Y_min--26.155--------
Market Cap3244762526.400-7%3463545142.8003310871300.133+5%3185462767.063+9%4071532975.715-15%2865010169.143+21%
Net Profit Margin--0.0120.011+12%0.009+34%0.010+20%0.010+21%
Operating Margin--0.0200.015+34%0.014+40%0.016+24%0.017+18%
Operating Ratio--0.9800.985-1%0.986-1%0.986-1%0.986-1%
Pb Ratio0.704-6%0.7480.720+4%0.739+1%0.983-24%0.727+3%
Pe Ratio11.274-6%11.96714.733-19%74.597-84%31.885-62%22.280-46%
Price Per Share15.450-6%16.40015.620+5%14.440+14%18.247-10%12.691+29%
Price To Free Cash Flow Ratio4.230-6%4.49012.349-64%7.497-40%3.969+13%1.985+126%
Price To Total Gains Ratio224.564-6%238.37294.259+153%-371.122+256%-56.118+124%-20.362+109%
Quick Ratio--0.9280.957-3%0.987-6%0.984-6%0.968-4%
Return On Assets--0.0060.005+14%0.004+37%0.005+24%0.005+23%
Return On Equity--0.0190.016+19%0.014+38%0.016+23%0.017+16%
Total Gains Per Share--0.0690.306-78%0.446-85%0.290-76%0.258-73%
Usd Book Value--4631724500.0004591171000.000+1%4323861750.000+7%4202679650.000+10%3731883187.500+24%
Usd Book Value Change Per Share--0.0690.306-78%0.446-85%0.290-76%0.258-73%
Usd Book Value Per Share--21.93121.668+1%19.636+12%18.969+16%16.597+32%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.3430.286+20%0.226+51%0.243+41%0.223+53%
Usd Free Cash Flow--192842000.00088920000.000+117%23832250.000+709%22550450.000+755%11275225.000+1610%
Usd Free Cash Flow Per Share--0.9130.420+117%0.219+316%0.353+159%0.353+159%
Usd Free Cash Flow To Equity Per Share--0.9130.420+117%0.219+316%0.353+159%0.353+159%
Usd Market Cap3244762526.400-7%3463545142.8003310871300.133+5%3185462767.063+9%4071532975.715-15%2865010169.143+21%
Usd Price Per Share15.450-6%16.40015.620+5%14.440+14%18.247-10%12.691+29%
Usd Profit--72358000.00060521500.000+20%49463375.000+46%53786850.000+35%51322537.500+41%
Usd Revenue--6083519000.0005699695625.000+7%5445487125.000+12%5391544925.000+13%5176734225.000+18%
Usd Total Gains Per Share--0.0690.306-78%0.446-85%0.290-76%0.258-73%
 EOD+4 -4MRQTTM+24 -10YOY+24 -105Y+24 -1010Y+26 -8

3.2. Fundamental Score

Let's check the fundamental score of Medipal Holdings Corp ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.274
Price to Book Ratio (EOD)Between0-10.704
Net Profit Margin (MRQ)Greater than00.012
Operating Margin (MRQ)Greater than00.020
Quick Ratio (MRQ)Greater than10.928
Current Ratio (MRQ)Greater than11.198
Debt to Asset Ratio (MRQ)Less than10.620
Debt to Equity Ratio (MRQ)Less than12.002
Return on Equity (MRQ)Greater than0.150.019
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Medipal Holdings Corp ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.182
Ma 20Greater thanMa 5015.464
Ma 50Greater thanMa 10015.621
Ma 100Greater thanMa 20015.947
OpenGreater thanClose15.450
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in JPY. All numbers in thousands.

Summary
Total Assets1,873,726,000
Total Liabilities1,161,153,000
Total Stockholder Equity579,950,000
 As reported
Total Liabilities 1,161,153,000
Total Stockholder Equity+ 579,950,000
Total Assets = 1,873,726,000

Assets

Total Assets1,873,726,000
Total Current Assets1,328,578,000
Long-term Assets545,148,000
Total Current Assets
Cash And Cash Equivalents 214,659,000
Net Receivables 814,405,000
Inventory 206,534,000
Other Current Assets 92,980,000
Total Current Assets  (as reported)1,328,578,000
Total Current Assets  (calculated)1,328,578,000
+/-0
Long-term Assets
Property Plant Equipment 272,466,000
Goodwill 11,887,000
Intangible Assets 27,769,000
Long-term Assets Other 32,586,000
Long-term Assets  (as reported)545,148,000
Long-term Assets  (calculated)344,708,000
+/- 200,440,000

Liabilities & Shareholders' Equity

Total Current Liabilities1,108,757,000
Long-term Liabilities52,396,000
Total Stockholder Equity579,950,000
Total Current Liabilities
Accounts payable 1,031,859,000
Other Current Liabilities 76,898,000
Total Current Liabilities  (as reported)1,108,757,000
Total Current Liabilities  (calculated)1,108,757,000
+/-0
Long-term Liabilities
Long-term Liabilities Other 35,366,000
Long-term Liabilities  (as reported)52,396,000
Long-term Liabilities  (calculated)35,366,000
+/- 17,030,000
Total Stockholder Equity
Common Stock22,398,000
Retained Earnings 426,127,000
Accumulated Other Comprehensive Income 66,394,000
Other Stockholders Equity 65,031,000
Total Stockholder Equity (as reported)579,950,000
Total Stockholder Equity (calculated)579,950,000
+/-0
Other
Capital Stock22,398,000
Cash and Short Term Investments 214,659,000
Common Stock Shares Outstanding 211,192
Liabilities and Stockholders Equity 1,873,725,000
Net Debt -179,295,000
Net Invested Capital 579,949,000
Net Working Capital 219,821,000
Property Plant and Equipment Gross 272,465,000
Short Long Term Debt Total 35,364,000



Balance Sheet

Currency in JPY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-30
> Total Assets 
0
1,172,314,000
1,117,287,000
0
1,153,051,000
1,200,843,000
1,166,486,000
1,236,857,000
1,221,606,000
1,300,963,000
1,284,679,000
1,261,762,000
1,243,571,000
1,312,145,000
1,274,411,000
1,280,986,000
1,278,522,000
1,362,109,000
1,328,601,000
1,321,861,000
1,323,289,000
1,405,539,000
1,400,792,000
1,359,214,000
1,360,166,000
1,462,728,000
1,454,800,000
1,434,769,000
1,446,035,000
1,569,490,000
1,497,310,000
1,513,975,000
1,487,791,000
1,572,095,000
1,525,912,000
1,552,879,000
1,549,273,000
1,693,303,000
1,618,819,000
1,647,131,000
1,618,102,000
1,686,327,000
1,617,911,000
1,638,505,000
1,649,707,000
1,735,543,000
1,644,279,000
1,656,094,000
1,651,769,000
1,744,345,000
1,679,934,000
1,697,649,000
1,724,150,000
1,778,449,000
1,709,474,000
1,717,354,000
1,735,280,000
1,807,375,000
1,703,871,000
1,779,472,000
1,815,781,000
1,873,726,000
1,873,726,0001,815,781,0001,779,472,0001,703,871,0001,807,375,0001,735,280,0001,717,354,0001,709,474,0001,778,449,0001,724,150,0001,697,649,0001,679,934,0001,744,345,0001,651,769,0001,656,094,0001,644,279,0001,735,543,0001,649,707,0001,638,505,0001,617,911,0001,686,327,0001,618,102,0001,647,131,0001,618,819,0001,693,303,0001,549,273,0001,552,879,0001,525,912,0001,572,095,0001,487,791,0001,513,975,0001,497,310,0001,569,490,0001,446,035,0001,434,769,0001,454,800,0001,462,728,0001,360,166,0001,359,214,0001,400,792,0001,405,539,0001,323,289,0001,321,861,0001,328,601,0001,362,109,0001,278,522,0001,280,986,0001,274,411,0001,312,145,0001,243,571,0001,261,762,0001,284,679,0001,300,963,0001,221,606,0001,236,857,0001,166,486,0001,200,843,0001,153,051,00001,117,287,0001,172,314,0000
   > Total Current Assets 
0
921,031,000
874,206,000
0
900,294,000
942,713,000
909,839,000
982,406,000
966,743,000
1,025,415,000
1,004,623,000
979,874,000
963,608,000
1,035,162,000
990,849,000
1,005,771,000
998,837,000
1,075,143,000
1,027,072,000
1,017,154,000
1,010,228,000
1,083,296,000
1,075,524,000
1,028,980,000
1,024,224,000
1,120,906,000
1,092,039,000
1,062,525,000
1,072,911,000
1,170,914,000
1,106,231,000
1,107,017,000
1,086,263,000
1,156,094,000
1,095,153,000
1,118,079,000
1,106,262,000
1,219,439,000
1,134,530,000
1,152,302,000
1,100,924,000
1,204,807,000
1,135,402,000
1,164,235,000
1,169,660,000
1,221,172,000
1,146,179,000
1,144,183,000
1,133,322,000
1,233,905,000
1,174,113,000
1,186,618,000
1,200,656,000
1,272,636,000
1,209,766,000
1,212,193,000
1,218,421,000
1,307,703,000
1,179,280,000
1,231,369,000
1,259,152,000
1,328,578,000
1,328,578,0001,259,152,0001,231,369,0001,179,280,0001,307,703,0001,218,421,0001,212,193,0001,209,766,0001,272,636,0001,200,656,0001,186,618,0001,174,113,0001,233,905,0001,133,322,0001,144,183,0001,146,179,0001,221,172,0001,169,660,0001,164,235,0001,135,402,0001,204,807,0001,100,924,0001,152,302,0001,134,530,0001,219,439,0001,106,262,0001,118,079,0001,095,153,0001,156,094,0001,086,263,0001,107,017,0001,106,231,0001,170,914,0001,072,911,0001,062,525,0001,092,039,0001,120,906,0001,024,224,0001,028,980,0001,075,524,0001,083,296,0001,010,228,0001,017,154,0001,027,072,0001,075,143,000998,837,0001,005,771,000990,849,0001,035,162,000963,608,000979,874,0001,004,623,0001,025,415,000966,743,000982,406,000909,839,000942,713,000900,294,0000874,206,000921,031,0000
       Cash And Cash Equivalents 
0
121,258,000
143,292,000
0
128,290,000
105,449,000
137,754,000
161,180,000
148,470,000
132,240,000
153,943,000
129,032,000
119,922,000
114,800,000
132,306,000
134,581,000
142,019,000
134,651,000
164,275,000
134,789,000
123,000,000
97,708,000
132,809,000
137,840,000
145,210,000
151,214,000
181,606,000
142,331,000
154,504,000
153,018,000
168,393,000
154,945,000
162,612,000
156,752,000
165,267,000
162,978,000
158,160,000
184,460,000
203,546,000
201,072,000
197,196,000
204,938,000
213,025,000
205,237,000
187,734,000
191,854,000
207,545,000
205,790,000
209,154,000
212,642,000
240,047,000
230,565,000
239,578,000
225,556,000
260,450,000
237,597,000
238,524,000
251,958,000
193,561,000
200,182,000
206,983,000
214,659,000
214,659,000206,983,000200,182,000193,561,000251,958,000238,524,000237,597,000260,450,000225,556,000239,578,000230,565,000240,047,000212,642,000209,154,000205,790,000207,545,000191,854,000187,734,000205,237,000213,025,000204,938,000197,196,000201,072,000203,546,000184,460,000158,160,000162,978,000165,267,000156,752,000162,612,000154,945,000168,393,000153,018,000154,504,000142,331,000181,606,000151,214,000145,210,000137,840,000132,809,00097,708,000123,000,000134,789,000164,275,000134,651,000142,019,000134,581,000132,306,000114,800,000119,922,000129,032,000153,943,000132,240,000148,470,000161,180,000137,754,000105,449,000128,290,0000143,292,000121,258,0000
       Short-term Investments 
0
0
-414,000
0
0
0
18,711,000
18,714,000
18,717,000
18,720,000
18,723,000
18,726,000
18,729,000
18,732,000
18,735,000
18,738,000
18,741,000
18,743,000
18,846,000
18,749,000
18,751,000
18,754,000
18,756,000
18,758,000
18,760,000
18,762,000
18,764,000
18,766,000
18,768,000
18,770,000
18,771,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
18,770,000
1,470,000
18,770,000
1,470,000
18,770,000
1,470,000
18,770,000
1,470,000
0
1,470,000
-33,811,000
2,070,000
0
02,070,000-33,811,0001,470,00001,470,00018,770,0001,470,00018,770,0001,470,00018,770,0001,470,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,770,00018,771,00018,770,00018,768,00018,766,00018,764,00018,762,00018,760,00018,758,00018,756,00018,754,00018,751,00018,749,00018,846,00018,743,00018,741,00018,738,00018,735,00018,732,00018,729,00018,726,00018,723,00018,720,00018,717,00018,714,00018,711,000000-414,00000
       Net Receivables 
0
598,942,000
613,815,000
0
587,686,000
626,747,000
630,809,000
598,183,000
595,346,000
635,432,000
671,499,000
613,301,000
618,569,000
666,895,000
696,068,000
643,962,000
623,408,000
669,090,000
624,599,000
650,849,000
649,302,000
703,419,000
693,409,000
658,340,000
653,205,000
714,057,000
678,121,000
690,867,000
685,180,000
742,440,000
699,484,000
703,637,000
676,936,000
723,228,000
688,575,000
708,353,000
706,738,000
749,185,000
696,938,000
717,039,000
673,800,000
726,831,000
686,293,000
712,476,000
738,274,000
744,493,000
688,683,000
693,134,000
685,078,000
749,936,000
766,855,000
726,278,000
719,543,000
764,356,000
774,684,000
737,155,000
737,693,000
780,506,000
797,179,000
775,310,000
783,802,000
814,405,000
814,405,000783,802,000775,310,000797,179,000780,506,000737,693,000737,155,000774,684,000764,356,000719,543,000726,278,000766,855,000749,936,000685,078,000693,134,000688,683,000744,493,000738,274,000712,476,000686,293,000726,831,000673,800,000717,039,000696,938,000749,185,000706,738,000708,353,000688,575,000723,228,000676,936,000703,637,000699,484,000742,440,000685,180,000690,867,000678,121,000714,057,000653,205,000658,340,000693,409,000703,419,000649,302,000650,849,000624,599,000669,090,000623,408,000643,962,000696,068,000666,895,000618,569,000613,301,000671,499,000635,432,000595,346,000598,183,000630,809,000626,747,000587,686,0000613,815,000598,942,0000
       Other Current Assets 
0
63,822,000
1,956,000
0
61,939,000
63,604,000
2,129,000
68,201,000
71,415,000
77,282,000
2,437,000
69,757,000
69,990,000
72,390,000
3,403,000
69,581,000
74,632,000
78,610,000
3,234,000
71,001,000
74,921,000
80,190,000
3,042,000
74,233,000
69,373,000
68,670,000
3,327,000
71,714,000
73,071,000
76,997,000
3,468,000
79,989,000
78,174,000
75,362,000
5,546,000
75,612,000
72,895,000
77,333,000
3,556,000
71,040,000
68,152,000
74,352,000
6,037,000
73,269,000
79,279,000
84,814,000
14,488,000
79,289,000
68,970,000
73,207,000
10,147,000
77,623,000
80,837,000
80,883,000
13,883,000
75,870,000
80,294,000
81,791,000
17,508,000
81,773,000
89,758,000
92,980,000
92,980,00089,758,00081,773,00017,508,00081,791,00080,294,00075,870,00013,883,00080,883,00080,837,00077,623,00010,147,00073,207,00068,970,00079,289,00014,488,00084,814,00079,279,00073,269,0006,037,00074,352,00068,152,00071,040,0003,556,00077,333,00072,895,00075,612,0005,546,00075,362,00078,174,00079,989,0003,468,00076,997,00073,071,00071,714,0003,327,00068,670,00069,373,00074,233,0003,042,00080,190,00074,921,00071,001,0003,234,00078,610,00074,632,00069,581,0003,403,00072,390,00069,990,00069,757,0002,437,00077,282,00071,415,00068,201,0002,129,00063,604,00061,939,00001,956,00063,822,0000
   > Long-term Assets 
0
251,283,000
243,081,000
0
252,757,000
258,130,000
256,647,000
254,451,000
254,863,000
275,548,000
280,056,000
281,888,000
279,963,000
276,983,000
283,560,000
275,215,000
279,685,000
286,965,000
301,525,000
304,705,000
313,060,000
322,241,000
325,265,000
330,233,000
335,941,000
341,820,000
362,760,000
372,242,000
373,123,000
398,575,000
391,078,000
406,957,000
401,527,000
415,999,000
430,755,000
434,799,000
443,010,000
473,864,000
484,285,000
494,828,000
517,176,000
481,518,000
482,505,000
474,269,000
480,044,000
514,369,000
498,096,000
511,909,000
518,445,000
510,438,000
505,821,000
511,031,000
523,494,000
505,813,000
499,708,000
505,161,000
516,859,000
499,672,000
524,591,000
548,103,000
556,629,000
545,148,000
545,148,000556,629,000548,103,000524,591,000499,672,000516,859,000505,161,000499,708,000505,813,000523,494,000511,031,000505,821,000510,438,000518,445,000511,909,000498,096,000514,369,000480,044,000474,269,000482,505,000481,518,000517,176,000494,828,000484,285,000473,864,000443,010,000434,799,000430,755,000415,999,000401,527,000406,957,000391,078,000398,575,000373,123,000372,242,000362,760,000341,820,000335,941,000330,233,000325,265,000322,241,000313,060,000304,705,000301,525,000286,965,000279,685,000275,215,000283,560,000276,983,000279,963,000281,888,000280,056,000275,548,000254,863,000254,451,000256,647,000258,130,000252,757,0000243,081,000251,283,0000
       Property Plant Equipment 
0
171,328,000
170,836,000
0
176,301,000
183,613,000
184,577,000
184,299,000
187,293,000
190,001,000
191,896,000
193,417,000
192,666,000
191,009,000
191,553,000
190,598,000
193,166,000
196,414,000
196,049,000
195,009,000
199,069,000
202,540,000
205,169,000
206,517,000
203,672,000
203,537,000
198,230,000
205,589,000
212,039,000
220,008,000
222,639,000
235,354,000
234,480,000
240,031,000
247,743,000
248,340,000
254,035,000
251,221,000
249,250,000
252,091,000
253,839,000
255,905,000
254,182,000
257,553,000
256,121,000
265,041,000
265,576,000
262,985,000
261,810,000
263,270,000
261,588,000
261,686,000
264,908,000
264,943,000
264,374,000
262,204,000
266,835,000
264,745,000
268,363,000
267,325,000
274,549,000
272,466,000
272,466,000274,549,000267,325,000268,363,000264,745,000266,835,000262,204,000264,374,000264,943,000264,908,000261,686,000261,588,000263,270,000261,810,000262,985,000265,576,000265,041,000256,121,000257,553,000254,182,000255,905,000253,839,000252,091,000249,250,000251,221,000254,035,000248,340,000247,743,000240,031,000234,480,000235,354,000222,639,000220,008,000212,039,000205,589,000198,230,000203,537,000203,672,000206,517,000205,169,000202,540,000199,069,000195,009,000196,049,000196,414,000193,166,000190,598,000191,553,000191,009,000192,666,000193,417,000191,896,000190,001,000187,293,000184,299,000184,577,000183,613,000176,301,0000170,836,000171,328,0000
       Goodwill 
0
6,685,000
5,916,000
0
4,470,000
3,747,000
1,800,000
1,496,000
95,000
79,000
63,000
47,000
31,000
15,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
604,000
0
0
0
25,029,000
12,414,000
12,151,000
11,887,000
11,887,00012,151,00012,414,00025,029,000000604,000000000000000000000000000000000000000000015,00031,00047,00063,00079,00095,0001,496,0001,800,0003,747,0004,470,00005,916,0006,685,0000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
163,458,000
169,724,000
171,873,000
204,383,433
26,611,629
266,903,678
228,079,000
248,845,000
211,468,000
210,617,000
202,951,000
211,996,000
238,021,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000238,021,000211,996,000202,951,000210,617,000211,468,000248,845,000228,079,000266,903,67826,611,629204,383,433171,873,000169,724,000163,458,000000000000000000000000000000000000
       Intangible Assets 
0
5,769,000
7,387,000
0
7,895,000
7,588,000
7,696,000
7,525,000
7,270,000
6,932,000
6,885,000
6,989,000
6,804,000
6,531,000
6,915,000
7,053,000
7,188,000
7,216,000
7,880,000
7,984,000
8,286,000
8,704,000
9,081,000
9,959,000
10,055,000
10,546,000
10,747,000
10,753,000
11,003,000
11,757,000
12,324,000
12,655,000
12,552,000
12,510,000
12,851,000
14,585,000
14,779,000
14,729,000
14,912,000
14,659,000
14,492,000
14,145,000
14,093,000
13,765,000
11,928,000
11,307,000
11,044,000
10,572,000
10,312,000
10,267,000
10,185,000
10,106,000
10,006,000
9,953,000
9,367,000
9,795,000
9,639,000
9,665,000
9,187,000
27,827,000
27,505,000
27,769,000
27,769,00027,505,00027,827,0009,187,0009,665,0009,639,0009,795,0009,367,0009,953,00010,006,00010,106,00010,185,00010,267,00010,312,00010,572,00011,044,00011,307,00011,928,00013,765,00014,093,00014,145,00014,492,00014,659,00014,912,00014,729,00014,779,00014,585,00012,851,00012,510,00012,552,00012,655,00012,324,00011,757,00011,003,00010,753,00010,747,00010,546,00010,055,0009,959,0009,081,0008,704,0008,286,0007,984,0007,880,0007,216,0007,188,0007,053,0006,915,0006,531,0006,804,0006,989,0006,885,0006,932,0007,270,0007,525,0007,696,0007,588,0007,895,00007,387,0005,769,0000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
0
0
1,000
4,000
2,000
1,000
2,000
3,000
1,000
1,000
2,000
1,000
2,000
1,000
1,000
1,000
1,000
1,000
2,000
4,000
1,000
1,000
0
4,000
1,000
2,000
2,000
4,000
1,000
3,000
2,000
4,000
2,000
2,000
2,000
3,000
2,000
2,000
2,000
4,000
2,000
1,000
2,000
4,000
3,000
2,000
0
02,0003,0004,0002,0001,0002,0004,0002,0002,0002,0003,0002,0002,0002,0004,0002,0003,0001,0004,0002,0002,0001,0004,00001,0001,0004,0002,0001,0001,0001,0001,0001,0002,0001,0002,0001,0001,0003,0002,0001,0002,0004,0001,000002,00000000000000000
> Total Liabilities 
0
873,406,000
822,787,000
0
858,956,000
904,230,000
835,494,000
904,187,000
886,030,000
956,255,000
943,696,000
919,403,000
900,502,000
965,887,000
920,070,000
929,885,000
923,075,000
994,079,000
946,712,000
933,131,000
927,799,000
1,002,245,000
993,314,000
946,540,000
935,529,000
1,029,974,000
997,198,000
971,869,000
977,710,000
1,082,908,000
1,008,984,000
1,017,115,000
985,945,000
1,056,905,000
1,004,749,000
1,024,059,000
1,009,038,000
1,135,531,000
1,046,164,000
1,071,533,000
1,019,758,000
1,101,975,000
1,025,064,000
1,047,418,000
1,071,090,000
1,135,337,000
1,036,857,000
1,034,487,000
1,018,757,000
1,115,175,000
1,040,997,000
1,052,116,000
1,066,929,000
1,128,960,000
1,060,382,000
1,058,313,000
1,060,534,000
1,129,416,000
1,015,815,000
1,069,383,000
1,101,163,000
1,161,153,000
1,161,153,0001,101,163,0001,069,383,0001,015,815,0001,129,416,0001,060,534,0001,058,313,0001,060,382,0001,128,960,0001,066,929,0001,052,116,0001,040,997,0001,115,175,0001,018,757,0001,034,487,0001,036,857,0001,135,337,0001,071,090,0001,047,418,0001,025,064,0001,101,975,0001,019,758,0001,071,533,0001,046,164,0001,135,531,0001,009,038,0001,024,059,0001,004,749,0001,056,905,000985,945,0001,017,115,0001,008,984,0001,082,908,000977,710,000971,869,000997,198,0001,029,974,000935,529,000946,540,000993,314,0001,002,245,000927,799,000933,131,000946,712,000994,079,000923,075,000929,885,000920,070,000965,887,000900,502,000919,403,000943,696,000956,255,000886,030,000904,187,000835,494,000904,230,000858,956,0000822,787,000873,406,0000
   > Total Current Liabilities 
0
827,345,000
781,382,000
0
820,417,000
865,973,000
798,172,000
865,216,000
848,413,000
911,651,000
900,635,000
876,665,000
854,147,000
919,859,000
873,371,000
886,504,000
880,091,000
951,504,000
895,271,000
882,850,000
878,656,000
950,524,000
941,800,000
897,583,000
884,911,000
978,550,000
941,127,000
910,364,000
913,001,000
1,014,595,000
947,073,000
948,454,000
917,885,000
988,351,000
928,252,000
946,693,000
933,271,000
1,027,863,000
940,728,000
969,075,000
913,566,000
1,007,203,000
932,617,000
959,440,000
982,335,000
1,042,040,000
945,600,000
939,593,000
923,034,000
1,022,482,000
952,835,000
964,073,000
978,558,000
1,074,969,000
1,008,816,000
1,005,260,000
1,005,928,000
1,078,446,000
971,519,000
1,013,989,000
1,047,336,000
1,108,757,000
1,108,757,0001,047,336,0001,013,989,000971,519,0001,078,446,0001,005,928,0001,005,260,0001,008,816,0001,074,969,000978,558,000964,073,000952,835,0001,022,482,000923,034,000939,593,000945,600,0001,042,040,000982,335,000959,440,000932,617,0001,007,203,000913,566,000969,075,000940,728,0001,027,863,000933,271,000946,693,000928,252,000988,351,000917,885,000948,454,000947,073,0001,014,595,000913,001,000910,364,000941,127,000978,550,000884,911,000897,583,000941,800,000950,524,000878,656,000882,850,000895,271,000951,504,000880,091,000886,504,000873,371,000919,859,000854,147,000876,665,000900,635,000911,651,000848,413,000865,216,000798,172,000865,973,000820,417,0000781,382,000827,345,0000
       Short-term Debt 
0
31,656,000
32,301,000
0
35,257,000
44,122,000
39,793,000
38,111,000
36,237,000
36,022,000
36,958,000
36,825,000
35,919,000
33,868,000
33,199,000
31,392,000
29,381,000
29,191,000
25,002,000
24,795,000
24,350,000
31,604,000
30,926,000
29,248,000
26,050,000
26,552,000
22,254,000
25,856,000
31,456,000
40,117,000
28,778,000
31,625,000
32,903,000
26,599,000
11,150,000
24,208,000
23,859,000
28,559,000
16,060,000
28,371,000
19,014,000
27,607,000
8,450,000
22,977,000
42,552,000
38,777,000
3,558,000
10,452,000
1,516,000
930,000
2,106,000
168,000
116,000
30,179,000
32,413,000
30,040,000
30,002,000
30,000,000
6,672,000
0
0
0
0006,672,00030,000,00030,002,00030,040,00032,413,00030,179,000116,000168,0002,106,000930,0001,516,00010,452,0003,558,00038,777,00042,552,00022,977,0008,450,00027,607,00019,014,00028,371,00016,060,00028,559,00023,859,00024,208,00011,150,00026,599,00032,903,00031,625,00028,778,00040,117,00031,456,00025,856,00022,254,00026,552,00026,050,00029,248,00030,926,00031,604,00024,350,00024,795,00025,002,00029,191,00029,381,00031,392,00033,199,00033,868,00035,919,00036,825,00036,958,00036,022,00036,237,00038,111,00039,793,00044,122,00035,257,000032,301,00031,656,0000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,225,000
26,614,000
38,676,000
9,220,932
967,502
8,684,955
7,371,000
6,814,000
6,407,000
8,450,000
22,977,000
42,552,000
38,777,000
3,558,000
10,452,000
1,516,000
930,000
350,000
168,000
116,000
30,179,000
30,078,000
30,040,000
30,002,000
30,000,000
0
0
0
0
000030,000,00030,002,00030,040,00030,078,00030,179,000116,000168,000350,000930,0001,516,00010,452,0003,558,00038,777,00042,552,00022,977,0008,450,0006,407,0006,814,0007,371,0008,684,955967,5029,220,93238,676,00026,614,00044,225,000000000000000000000000000000000000
       Accounts payable 
0
762,590,000
716,767,000
0
743,636,000
788,659,000
719,437,000
783,436,000
757,798,000
828,086,000
820,137,000
803,617,000
781,535,000
850,476,000
798,183,000
807,138,000
791,922,000
864,633,000
811,933,000
818,696,000
807,389,000
882,500,000
869,132,000
823,411,000
808,057,000
903,349,000
862,644,000
842,093,000
835,190,000
930,482,000
863,591,000
868,079,000
834,533,000
921,794,000
860,602,000
878,030,000
854,953,000
953,512,000
867,111,000
883,994,000
835,980,000
934,123,000
869,647,000
888,399,000
885,820,000
951,378,000
883,624,000
876,890,000
869,931,000
967,682,000
900,014,000
911,106,000
915,149,000
989,349,000
907,997,000
913,076,000
905,375,000
987,098,000
890,966,000
941,371,000
951,513,000
1,031,859,000
1,031,859,000951,513,000941,371,000890,966,000987,098,000905,375,000913,076,000907,997,000989,349,000915,149,000911,106,000900,014,000967,682,000869,931,000876,890,000883,624,000951,378,000885,820,000888,399,000869,647,000934,123,000835,980,000883,994,000867,111,000953,512,000854,953,000878,030,000860,602,000921,794,000834,533,000868,079,000863,591,000930,482,000835,190,000842,093,000862,644,000903,349,000808,057,000823,411,000869,132,000882,500,000807,389,000818,696,000811,933,000864,633,000791,922,000807,138,000798,183,000850,476,000781,535,000803,617,000820,137,000828,086,000757,798,000783,436,000719,437,000788,659,000743,636,0000716,767,000762,590,0000
       Other Current Liabilities 
0
33,099,000
32,314,000
0
41,524,000
33,192,000
38,942,000
43,669,000
54,378,000
47,543,000
43,540,000
36,223,000
36,693,000
35,515,000
41,989,000
47,974,000
58,788,000
57,680,000
58,336,000
39,359,000
46,917,000
36,420,000
41,742,000
44,924,000
50,804,000
48,649,000
56,229,000
42,415,000
46,355,000
43,996,000
54,704,000
48,750,000
50,449,000
39,958,000
56,500,000
44,455,000
54,459,000
45,792,000
57,557,000
56,710,000
58,572,000
45,473,000
54,520,000
48,064,000
53,963,000
51,885,000
58,418,000
52,251,000
51,587,000
53,870,000
50,715,000
52,799,000
63,293,000
55,441,000
54,347,000
52,457,000
55,759,000
51,602,000
73,624,000
72,618,000
95,823,000
76,898,000
76,898,00095,823,00072,618,00073,624,00051,602,00055,759,00052,457,00054,347,00055,441,00063,293,00052,799,00050,715,00053,870,00051,587,00052,251,00058,418,00051,885,00053,963,00048,064,00054,520,00045,473,00058,572,00056,710,00057,557,00045,792,00054,459,00044,455,00056,500,00039,958,00050,449,00048,750,00054,704,00043,996,00046,355,00042,415,00056,229,00048,649,00050,804,00044,924,00041,742,00036,420,00046,917,00039,359,00058,336,00057,680,00058,788,00047,974,00041,989,00035,515,00036,693,00036,223,00043,540,00047,543,00054,378,00043,669,00038,942,00033,192,00041,524,000032,314,00033,099,0000
   > Long-term Liabilities 
0
46,061,000
41,405,000
0
38,539,000
38,257,000
37,322,000
38,971,000
37,617,000
44,604,000
43,061,000
42,738,000
46,355,000
46,028,000
46,699,000
43,381,000
42,984,000
42,575,000
51,441,000
50,281,000
49,143,000
51,721,000
51,514,000
48,957,000
50,618,000
51,424,000
56,071,000
61,505,000
64,709,000
68,313,000
61,911,000
68,661,000
68,060,000
68,554,000
76,497,000
77,366,000
75,767,000
107,668,000
105,436,000
102,458,000
106,192,000
94,772,000
92,447,000
87,978,000
88,755,000
93,297,000
91,257,000
94,894,000
95,723,000
92,693,000
88,162,000
88,043,000
88,371,000
53,991,000
51,566,000
53,053,000
54,606,000
50,970,000
44,296,000
55,394,000
53,827,000
52,396,000
52,396,00053,827,00055,394,00044,296,00050,970,00054,606,00053,053,00051,566,00053,991,00088,371,00088,043,00088,162,00092,693,00095,723,00094,894,00091,257,00093,297,00088,755,00087,978,00092,447,00094,772,000106,192,000102,458,000105,436,000107,668,00075,767,00077,366,00076,497,00068,554,00068,060,00068,661,00061,911,00068,313,00064,709,00061,505,00056,071,00051,424,00050,618,00048,957,00051,514,00051,721,00049,143,00050,281,00051,441,00042,575,00042,984,00043,381,00046,699,00046,028,00046,355,00042,738,00043,061,00044,604,00037,617,00038,971,00037,322,00038,257,00038,539,000041,405,00046,061,0000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,927,000
61,032,000
62,897,000
74,079,549
8,449,231
83,974,659
63,720,000
68,904,000
58,934,000
58,010,000
54,868,000
56,669,000
61,888,000
60,528,000
64,384,000
65,303,000
62,363,000
57,939,000
57,856,000
58,221,000
53,993,000
51,570,000
53,055,000
54,609,000
50,973,000
44,298,000
0
0
0
00044,298,00050,973,00054,609,00053,055,00051,570,00053,993,00058,221,00057,856,00057,939,00062,363,00065,303,00064,384,00060,528,00061,888,00056,669,00054,868,00058,010,00058,934,00068,904,00063,720,00083,974,6598,449,23174,079,54962,897,00061,032,00050,927,000000000000000000000000000000000000
> Total Stockholder Equity
0
298,900,000
294,500,000
0
294,095,000
296,613,000
289,951,000
291,538,000
293,621,000
302,284,000
299,282,000
300,120,000
300,438,000
303,158,000
310,206,000
306,607,000
309,570,000
310,893,000
323,211,000
329,575,000
335,008,000
342,251,000
345,846,000
350,263,000
360,471,000
367,410,000
390,058,000
393,783,000
397,620,000
414,078,000
414,937,000
422,399,000
425,508,000
437,135,000
441,610,000
447,343,000
456,096,000
471,530,000
484,667,000
484,414,000
504,216,000
490,231,000
496,879,000
494,332,000
478,762,000
498,673,000
500,317,000
512,346,000
520,757,000
515,203,000
523,014,000
528,583,000
537,571,000
532,436,000
530,305,000
538,917,000
551,964,000
553,512,000
561,358,000
581,276,000
582,943,000
579,950,000
579,950,000582,943,000581,276,000561,358,000553,512,000551,964,000538,917,000530,305,000532,436,000537,571,000528,583,000523,014,000515,203,000520,757,000512,346,000500,317,000498,673,000478,762,000494,332,000496,879,000490,231,000504,216,000484,414,000484,667,000471,530,000456,096,000447,343,000441,610,000437,135,000425,508,000422,399,000414,937,000414,078,000397,620,000393,783,000390,058,000367,410,000360,471,000350,263,000345,846,000342,251,000335,008,000329,575,000323,211,000310,893,000309,570,000306,607,000310,206,000303,158,000300,438,000300,120,000299,282,000302,284,000293,621,000291,538,000289,951,000296,613,000294,095,0000294,500,000298,900,0000
   Common Stock
0
22,398,000
22,398,000
0
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,000
22,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,00022,398,000022,398,00022,398,0000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,148,000
74,127,000
74,036,000
63,441,000
60,719,000
65,892,000
69,883,000
63,739,000
62,627,000
70,585,000
70,109,000
66,394,000
66,394,00070,109,00070,585,00062,627,00063,739,00069,883,00065,892,00060,719,00063,441,00074,036,00074,127,00098,148,00000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
114,312,000
111,305,000
0
109,625,000
109,048,000
108,770,000
107,028,000
107,276,000
118,112,000
118,077,000
119,152,000
119,152,000
119,560,000
121,457,000
110,741,000
109,480,000
110,103,000
119,936,000
120,473,000
119,649,000
122,873,000
121,654,000
123,196,000
128,241,000
130,694,000
149,439,000
150,251,000
147,415,000
157,283,000
149,486,000
150,515,000
148,057,000
153,590,000
152,601,000
156,675,000
155,013,000
162,451,000
168,543,000
164,226,000
176,657,000
153,689,000
153,239,000
147,272,000
123,004,000
136,048,000
127,357,000
136,892,000
140,278,000
135,101,000
37,177,000
62,105,000
62,104,000
61,576,000
61,577,000
61,575,000
61,613,000
61,610,000
61,610,000
67,211,000
63,559,000
65,031,000
65,031,00063,559,00067,211,00061,610,00061,610,00061,613,00061,575,00061,577,00061,576,00062,104,00062,105,00037,177,000135,101,000140,278,000136,892,000127,357,000136,048,000123,004,000147,272,000153,239,000153,689,000176,657,000164,226,000168,543,000162,451,000155,013,000156,675,000152,601,000153,590,000148,057,000150,515,000149,486,000157,283,000147,415,000150,251,000149,439,000130,694,000128,241,000123,196,000121,654,000122,873,000119,649,000120,473,000119,936,000110,103,000109,480,000110,741,000121,457,000119,560,000119,152,000119,152,000118,077,000118,112,000107,276,000107,028,000108,770,000109,048,000109,625,0000111,305,000114,312,0000



Balance Sheet

Currency in JPY. All numbers in thousands.




Cash Flow

Currency in JPY. All numbers in thousands.




Income Statement

Currency in JPY. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue3,360,008,000
Cost of Revenue-3,147,891,000
Gross Profit212,117,000212,117,000
 
Operating Income (+$)
Gross Profit212,117,000
Operating Expense-163,143,000
Operating Income48,974,00048,974,000
 
Operating Expense (+$)
Research Development103,000
Selling General Administrative144,235,000
Selling And Marketing Expenses18,805,000
Operating Expense163,143,000163,143,000
 
Net Interest Income (+$)
Interest Income101,000
Interest Expense-34,000
Other Finance Cost-0
Net Interest Income67,000
 
Pretax Income (+$)
Operating Income48,974,000
Net Interest Income67,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)70,061,00027,887,000
EBIT - interestExpense = 48,940,000
60,544,000
38,840,000
Interest Expense34,000
Earnings Before Interest and Taxes (EBIT)48,974,00070,095,000
Earnings Before Interest and Taxes (EBITDA)63,622,000
 
After tax Income (+$)
Income Before Tax70,061,000
Tax Provision-21,738,000
Net Income From Continuing Ops48,323,00048,323,000
Net Income38,806,000
Net Income Applicable To Common Shares38,806,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses3,311,034,000
Total Other Income/Expenses Net21,087,000-67,000
 

Technical Analysis of Medipal
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medipal. The general trend of Medipal is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medipal's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medipal Holdings Corp ADR.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 15.45 < 15.45 < 15.45.

The bearish price targets are: 15.45 > 15.45 > 15.45.

Tweet this
Medipal Holdings Corp ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medipal Holdings Corp ADR. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medipal Holdings Corp ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medipal Holdings Corp ADR. The current macd is -0.05429599.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medipal price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Medipal. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Medipal price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Medipal Holdings Corp ADR Daily Moving Average Convergence/Divergence (MACD) ChartMedipal Holdings Corp ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medipal Holdings Corp ADR. The current adx is 53.25.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Medipal shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Medipal Holdings Corp ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medipal Holdings Corp ADR. The current sar is 15.50.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Medipal Holdings Corp ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medipal Holdings Corp ADR. The current rsi is 23.18. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Medipal Holdings Corp ADR Daily Relative Strength Index (RSI) ChartMedipal Holdings Corp ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medipal Holdings Corp ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medipal price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Medipal Holdings Corp ADR Daily Stochastic Oscillator ChartMedipal Holdings Corp ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medipal Holdings Corp ADR. The current cci is -39.21568627.

Medipal Holdings Corp ADR Daily Commodity Channel Index (CCI) ChartMedipal Holdings Corp ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medipal Holdings Corp ADR. The current cmo is -70.48736832.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Medipal Holdings Corp ADR Daily Chande Momentum Oscillator (CMO) ChartMedipal Holdings Corp ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medipal Holdings Corp ADR. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Medipal Holdings Corp ADR Daily Williams %R ChartMedipal Holdings Corp ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medipal Holdings Corp ADR.

Medipal Holdings Corp ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medipal Holdings Corp ADR. The current atr is 0.01045125.

Medipal Holdings Corp ADR Daily Average True Range (ATR) ChartMedipal Holdings Corp ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medipal Holdings Corp ADR. The current obv is 18,700.

Medipal Holdings Corp ADR Daily On-Balance Volume (OBV) ChartMedipal Holdings Corp ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medipal Holdings Corp ADR. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Medipal Holdings Corp ADR Daily Money Flow Index (MFI) ChartMedipal Holdings Corp ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medipal Holdings Corp ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Medipal Holdings Corp ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medipal Holdings Corp ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.182
Ma 20Greater thanMa 5015.464
Ma 50Greater thanMa 10015.621
Ma 100Greater thanMa 20015.947
OpenGreater thanClose15.450
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medipal with someone you think should read this too:
  • Are you bullish or bearish on Medipal? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medipal? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medipal Holdings Corp ADR

I send you an email if I find something interesting about Medipal Holdings Corp ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Medipal Holdings Corp ADR.

Receive notifications about Medipal Holdings Corp ADR in your mailbox!